---
$id: https://graph.org.ai/products/commodity/51101907
$type: Product
source: UNSPSC
code: "51101907"
title: "Pyrimethamine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pyrimethamine

**UNSPSC Code**: 51101907
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dihydrofolate reductase inhibitor and antimalarial agent with the molecular formula C12H13ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z3614QOX8W, chemically known as 2,4-pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl- but generally known as pyrimethamine, which bears US NIH Compound Identifier 4993. European Medicines Agency schedules Pyrimethamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10169MIG. The term PYRIMETHAMINE is an International Non-Proprietary Name. World Health Organization schedules pyrimethamine in its Anatomical Therapeutic Chemical (ATC) Classification. PYRIMETHAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pyrimethamine under HS 29335995 and SITC 51576. As of Q4 2014, PYRIMETHAMINE remains the US FDA Preferred Term for this commodity. Pyrimethamine bears US NLM identifiers UMLS ID C0034283 and NCI Concept Code C788. SMILES: CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)CL.

